Researchers identify genes connecting endocrine disruption to genital malformations

Circadian dysregulation may increase risk of type-2 diabetes

Panel rejects biosimilar insulin for European market

24 Nov 2015

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended against the European marketing of the biosimilar human insulin Solumarv (Marvel LifeSciences).

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read